featured
Effect of Inhaled Treprostinil Dose in Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Chest
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Inhaled Treprostinil Dose in Pulmonary Hypertension Associated with Interstitial Lung Disease and Its Effects on Clinical Outcomes
Chest 2022 Sep 14;[EPub Ahead of Print], SD Nathan, C Deng, CS King, HM DuBrock, J Elwing, S Rajagopal, F Rischard, S Sahay, M Broderick, E Shen, P Smith, VF Tapson, AB WaxmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.